Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus

In rats, esophagogastroduodenal anastomosis (EGDA) without concomitant chemical carcinogen treatment can lead to columnar-lined esophagus (CLE) including metaplasia, dysplasia, and esophageal adenocarcinoma (EAC). This study describes the morphology and phenotypic features of CLE and EAC in the rat model and compares them with the corresponding lesions in human Barrett's esophagus (BE). Swiss roll preparations of esophagi of EGDA rats and biopsies from human BE containing specialized intestinal metaplasia (SIM) and EAC were examined. The esophagi of EGDA rats showed esophagitis, CLE, islands of multilayered epithelium (MLE), dysplasia and EAC. The CLE had features of specialized intestinal metaplasia. MLE frequently occurred at the neo-squamocolumnar junction and occasionally in the mid-esophagus in isolated foci. Scattered mucinous cells in esophageal squamous epithelium were also found. The CLE and MLE in EGDA rats resembled the lesions described in human BE in morphology, mucin features and expression of differentiation markers (CK7, CK20, Das-1, villin, and pS2/TFF1). Invasive EAC in EGDA rat is of well-differentiated mucinous type, which is in contrast to the variably differentiated glandular type of adenocarcinoma in human BE. p53, c-myc, and cyclooxygenase 2 are expressed in both the rat and human SIM and EAC. These studies indicate that, not withstanding small differences, SIM and EAC induced in EGDA rats are similar to the corresponding lesions in human BE. EGDA rats may serve as a useful model to study the pathogenesis, molecular biology, and chemopreventive interventions of human BE and EAC.

[1]  G. Jenkins,et al.  The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. , 2003, Carcinogenesis.

[2]  Kenneth K Wang,et al.  Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.

[3]  J. Goldblum,et al.  Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. , 2000, Gastroenterology.

[4]  Wei Ding,et al.  An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. , 1999, Carcinogenesis.

[5]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[6]  D. Sheahan,et al.  Comparative histochemistry of gastrointestinal mucosubstances. , 1976, The American journal of anatomy.

[7]  K. Washington,et al.  Pathology of mouse models of intestinal cancer: consensus report and recommendations. , 2003, Gastroenterology.

[8]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[9]  M. Matsuda,et al.  Immunohistochemical study of p53, c-erbB-2, and PCNA in Barrett's esophagus with dysplasia and adenocarcinoma arising from experimental acid or alkaline reflux model , 2001, Journal of Gastroenterology.

[10]  R. Haggitt,et al.  Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.

[11]  R. Poulsom,et al.  Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. , 1993, The American journal of physiology.

[12]  R. Schlemper.  International Consensus Classification of Gastrointestinal Epithelial Neoplasia: Usefulness for Esophageal Squamous Epithelium , 2002 .

[13]  R. Poulsom,et al.  Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. , 2000, Carcinogenesis.

[14]  T. Hattori,et al.  Reflux of duodenal or gastro‐duodenal contents induces esophageal carcinoma in rats , 1996, International journal of cancer.

[15]  J. Jankowski,et al.  Barrett's metaplasia , 2000, The Lancet.

[16]  J. Hagen,et al.  Is adenocarcinoma following esophagoduodenostomy without carcinogen in the rat reflux-induced? , 2000, The Journal of surgical research.

[17]  Gary G. Koch,et al.  Categorical Data Analysis Using The SAS1 System , 1995 .

[18]  J. Dekker,et al.  Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. , 2002, Human pathology.

[19]  C. S. Yang,et al.  Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. , 2001, Carcinogenesis.

[20]  B. Liu,et al.  Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. , 1997, Carcinogenesis.

[21]  D. Wakelin,et al.  Upregulation of the oncogene c-myc in Barrett’s adenocarcinoma: induction of c-myc by acidified bile acid in vitro , 2003, Gut.

[22]  J. Jass,et al.  The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma , 1981, The Histochemical Journal.

[23]  J. Peters,et al.  Gastric juice protects against the development of esophageal adenocarcinoma in the rat. , 1996, Annals of surgery.

[24]  C. Rubio.  Histocytologic Criteria for Squamous Cell Carcinoma In Situ of the Esophagus , 2002 .

[25]  M. Fang,et al.  Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. , 2002, Carcinogenesis.

[26]  R. Goyal,et al.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.

[27]  J. Bombí,et al.  Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. , 1989, Cancer research.

[28]  M. Herderich,et al.  Duodenogastric reflux and foregut carcinogenesis: analysis of duodenal juice in a rodent model of cancer. , 2000, Carcinogenesis.

[29]  P. Laird,et al.  Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux. , 1999, The Journal of surgical research.

[30]  B. Ransil,et al.  Prospective evaluation of multilayered epithelium in Barrett's esophagus , 2001, American Journal of Gastroenterology.

[31]  D. Beer,et al.  Identification of intestinal‐type Barrett's metaplasia by using the intestine‐specific protein villin and esophageal brush cytology , 1999, Molecular carcinogenesis.

[32]  P. Amenta,et al.  Detection of a Shared Colon Epithelial Epitope on Barrett Epithelium by a Novel Monoclonal Antibody , 1994, Annals of Internal Medicine.

[33]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[34]  R. Odze,et al.  Phenotypic Characteristics of a Distinctive Multilayered Epithelium Suggests That It Is a Precursor in the Development of Barrett's Esophagus , 2001, The American journal of surgical pathology.

[35]  G. Yang,et al.  Oxidative damage in an esophageal adenocarcinoma model with rats. , 2000, Carcinogenesis.

[36]  R. Goyal,et al.  Phenotype of Barrett's Esophagus and Intestinal Metaplasia of the Distal Esophagus and Gastroesophageal Junction: An Immunohistochemical Study of Cytokeratins 7 and 20, Das-1 and 45MI , 2001, The American journal of surgical pathology.

[37]  J. Witjes,et al.  The prognostic value of a primary inverted papilloma of the urinary tract. , 1997, The Journal of urology.

[38]  D. Antonioli,et al.  Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. , 1997, Gastroenterology.

[39]  T. Smyrk,et al.  Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. , 1992, Surgery.